Why people look for a Qure.ai alternative
None of the common reasons is a knock on Qure.ai. Its qXR chest X-ray product is recommended in WHO TB screening guidance and deployed in public-health programmes across 90+ countries; qER is CE-certified for head-CT critical findings. The buyers who search for alternatives usually have a need the software-vendor model itself doesn't cover:
- They need signed reports, not software. Qure.ai provides detection and triage; your own radiologists still interpret every study and sign the report. Facilities without in-house radiologists — or with too few — need a reporting service, which no AI software licence provides.
- They need breadth beyond chest X-ray and CT triage. Qure's portfolio is strongest on chest X-ray, head CT and lung CT. A hospital whose worklist spans MRI, mammography and the full range of routine studies needs coverage the point solutions don't offer.
- The budget model doesn't fit. Enterprise AI software is typically subscription licensing — a fixed cost that assumes volume and an in-house team to use it. Smaller centres often prefer paying per completed report, where the cost tracks revenue.
- They want to evaluate several vendors, not commit to one. Institutions running a formal AI procurement often want Qure.ai tested side-by-side against competitors on their own data — a job for an evaluation platform rather than any single vendor.
The sections below match each of those needs to the alternative built for it. For background on the software-vendor versus reporting-service distinction that runs through all of this, see our guide to radiology AI companies in India and the radiology AI overview.
Alternatives at a glance
| If you need… | Look at | What you get |
|---|---|---|
| Final signed reports, end to end | 5C Network | AI pre-read + radiologist-signed report, ~30-min average |
| Multi-vendor AI validation | CARPL.ai | One platform to trial, deploy and monitor many AI tools |
| Enterprise emergency triage | Aidoc | FDA-cleared critical-findings alerts, primarily on CT |
| Cancer-detection AI | Lunit | Chest X-ray and mammography cancer detection scores |
| Broad findings per study | Annalise.ai | 130+ findings per chest X-ray or brain CT pass |
| TB screening at scale | DeepTek (or Qure.ai itself) | WHO-recommended chest X-ray TB screening + reporting arm |
The alternatives, by need
If you need an end-to-end reporting service
5C Network
AI-native reporting service · Bangalore, India · est. 2017
The alternative for the most common unmet need: you don't want detection software for radiologists you don't have — you want the report. 5C builds its own clinical AI (Bionic, 0.93 F1 across hundreds of pathologies, backed by peer-reviewed and arXiv-published research) but sells the outcome: every study gets a Bionic AI pre-read, an NMC-registered radiologist — subspecialty-matched where needed, from a panel of around 400 — reviews, edits and signs it, and a QC layer checks the output. 2,000+ facilities, 15,000+ scans a day, roughly a 30-minute average turnaround across X-ray, CT, MRI and Mammography, priced per scan rather than as an enterprise licence. The trade-off versus Qure.ai is the mirror image of its strength: 5C is India-focused, and if your radiologists are staying in-house and only need a triage layer, a software vendor is the better-shaped purchase. Head-to-head detail: 5C Network vs Qure.ai.
If you need multi-vendor AI validation
CARPL.ai
AI validation & deployment platform · incubated at Mahajan Imaging
Strictly speaking not a Qure.ai substitute but the layer above it: CARPL is a marketplace and orchestration platform that lets hospitals discover, validate, deploy and monitor a wide range of third-party AI applications — Qure.ai's among them — through a single integration. If your real question is “is Qure.ai the best tool for our case mix, or is a competitor better?”, this is the infrastructure that answers it with your own data rather than vendor brochures.
If you need enterprise triage or detection software
Aidoc, Lunit and Annalise.ai
AI software vendors · Tel Aviv / Seoul / Sydney
These are Qure.ai's true like-for-like peers — software your own radiologists use — each with a different centre of gravity:
- Aidoc (est. 2016) is the best-known name in always-on emergency triage, with an extensive portfolio of FDA-cleared algorithms for critical findings — stroke, pulmonary embolism, intracranial haemorrhage — primarily on CT. See 5C vs Aidoc.
- Lunit (est. 2013) is deliberately narrow: cancer detection on chest X-ray (INSIGHT CXR) and mammography (INSIGHT MMG), with FDA and CE clearances and strong published screening evidence. See 5C vs Lunit.
- Annalise.ai (est. 2019) takes the opposite approach: comprehensive-findings AI covering 130+ findings per chest X-ray or brain CT study, cleared by the FDA, CE and TGA. See 5C vs Annalise.ai.
The honest caveat for Indian buyers: all three are concentrated in their home and Western markets, with limited India operations, foreign-currency enterprise pricing, and models that may not have been validated on Indian patient populations. Check CDSCO registration status and local support before shortlisting.
If you need TB screening at public-health scale
DeepTek — and, honestly, Qure.ai itself
AI software + reporting · Pune, India · est. 2017
DeepTek is the main Indian alternative for programme-scale chest X-ray TB screening: its solution is recommended by the World Health Organization, its Genki platform runs on mobile screening vans, and — unusually for this market — it pairs the AI with a teleradiology reporting service and an AI-enabled cloud PACS (Augmento), so it spans both sides of the software/service divide. But this is also the segment where the honest advice is that Qure.ai remains one of the strongest choices anywhere: qXR is recommended in WHO TB screening guidance and proven across public-health programmes in 90+ countries. If TB screening is your entire requirement, trial both on your own population rather than assuming either wins. See 5C vs DeepTek for how DeepTek's reporting arm compares.
Capabilities and regulatory status evolve quickly in this market — verify current products directly with each vendor. For the wider landscape beyond these names, see the full guide to radiology AI companies in India.
How to run the evaluation
Whichever alternative you shortlist, the checklist is the same:
- Decide what you're buying first. Alerts and scores for your radiologists, or a signed report? This one question eliminates half the market either way and determines staffing, liability and pricing downstream.
- Verify India regulatory status. CDSCO registration under the Medical Device Rules, 2017 is what authorises Indian clinical use — an FDA or CE mark alone does not. Ask for the registration number and device class.
- Insist on validation against your case mix. Published evidence matters, but so does whether the model was validated on a population resembling yours.
- Confirm data compliance. Patient data handling falls under the DPDP Act, 2023; ask where studies are processed and stored.
- Trial before committing. Run a paid or free pilot on your own studies and judge the output — not the demo.
For the regulatory detail, see the radiology AI in India guide.
Frequently asked questions
Is there an Indian alternative to Qure.ai?
Yes — three notable ones, each serving a different need. 5C Network (Bangalore, est. 2017) is an AI-native reporting service: its Bionic AI pre-reads every study and an NMC-registered radiologist signs the final report, covering 2,000+ facilities at roughly a 30-minute average turnaround. DeepTek (Pune, est. 2017) pairs WHO-recommended chest X-ray TB screening with a teleradiology reporting service. CARPL.ai, incubated at Mahajan Imaging, is a validation and deployment platform for evaluating many third-party AI tools at once. Which one is the right alternative depends on whether you need reports, screening or evaluation infrastructure.
What is the difference between Qure.ai and 5C Network?
They sell different products. Qure.ai sells AI software — qXR, qER and qCT provide detection and triage that your own radiologists act on; no report is signed by Qure. 5C Network sells the finished report: a Bionic AI pre-read reviewed, edited and signed by an NMC-registered radiologist, delivered in about 30 minutes on average across X-ray, CT, MRI and Mammography. If you have radiologists and want AI assistance, Qure.ai fits; if you need the signed report itself, 5C does. Some facilities run both — Qure for screening, 5C for clinical reads.
Are there free or open-source alternatives to Qure.ai?
Research-grade open-source models exist — the CheXNet family and libraries like TorchXRayVision offer chest X-ray classifiers trained on public datasets — but they are not practical clinical alternatives. They carry no CDSCO, FDA or CE clearance, are validated on research datasets rather than your patient population, come with no PACS integration, support or liability cover, and published evaluations show performance drops when they are applied outside their training domain. They are useful for research and prototyping; for clinical deployment in India, a registered product (or a reporting service whose radiologists carry the clinical responsibility) is the realistic path.
Which Qure.ai alternative is best for a small diagnostic centre?
For most small Indian diagnostic centres, the honest answer is that AI software licences solve the wrong problem — the bottleneck is usually getting studies reported at all, not giving in-house radiologists a triage tool. An AI-native reporting service such as 5C Network delivers signed reports on a pay-per-scan basis with no radiologist hiring, no software integration project and no enterprise licence. If the centre does have its own radiologists and mainly runs chest X-ray screening, DeepTek and Qure.ai itself are both credible options worth trialling on your own case mix.
Can I use Qure.ai and an alternative together?
Yes, and some facilities do. The common patterns: Qure.ai's qXR for programme-scale TB screening with an AI-native reporting service like 5C Network handling the clinical reads that need a signed report; or a validation platform like CARPL used to run Qure.ai alongside competing tools and compare them on the hospital's own data before committing. The products are complementary because they sit at different points in the workflow — detection versus final report versus evaluation infrastructure.
Need reports, not software?
If what brought you here is the need for signed reports rather than another AI licence, tell us your scan volume and modality mix — we'll show you how 5C's hybrid-intelligence workflow compares, with the first 10 cases free so you can judge the output yourself.
